REVIEW 3 cited by
DrugPilot: LLM-based Parameterized Reasoning Agent for Drug Discovery
Not yet reviewed by Pith; the record is open.
This paper has not been read by Pith yet. Machine review is queued; the pith claim, tier, and objections will appear here once it completes.
SPECIMEN: schema-true, not a live event
T0 review · schema-true
One-sentence machine reading of the paper's core claim.
pith:XXXXXXXX · record.json · timestamp
read the original abstract
Large language models (LLMs) integrated with autonomous agents hold significant potential for advancing scientific discovery through automated reasoning and task execution. However, applying LLM agents to drug discovery is still constrained by challenges such as large-scale multimodal data processing, limited task automation, and poor support for domain-specific tools. To overcome these limitations, we introduce DrugPilot, a LLM-based agent system with a parameterized reasoning architecture designed for end-to-end scientific workflows in drug discovery. DrugPilot enables multi-stage research processes by integrating structured tool use with a novel parameterized memory pool. The memory pool converts heterogeneous data from both public sources and user-defined inputs into standardized representations. This design supports efficient multi-turn dialogue, reduces information loss during data exchange, and enhances complex scientific decision-making. To support training and benchmarking, we construct a drug instruction dataset covering eight core drug discovery tasks. Under the Berkeley function-calling benchmark, DrugPilot significantly outperforms state-of-the-art agents such as ReAct and LoT, achieving task completion rates of 98.0%, 93.5%, and 64.0% for simple, multi-tool, and multi-turn scenarios, respectively. These results highlight DrugPilot's potential as a versatile agent framework for computational science domains requiring automated, interactive, and data-integrated reasoning.
Forward citations
Cited by 3 Pith papers
-
Evaluating Agentic Bioinformatics through Function, Evidence, and Validation
Agentic bioinformatics systems mostly demonstrate planning and tool execution but rarely prospective empirical validation, so the paper argues evaluation should center on inspectable workflow trajectories (FEV) rather...
-
An Auditable Agent Platform For Automated Molecular Optimisation
A hierarchical multi-agent LLM platform with recorded provenance improved average predicted binding affinity for AKT1 by 31%, while single-agent runs favored drug-likeness.
-
Exploring Modularity of Agentic Systems for Drug Discovery
On 26 chemistry questions, swapping the LLM, agent type, or prompt in an LLM agent changes its scores so much that the system cannot be treated as modular.
Discussion (0). Sign in to comment.